Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000234011 | SCV000286094 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571370 | SCV000663954 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800593 | SCV002047067 | benign | not provided | 2021-05-13 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001808629 | SCV002057105 | benign | Intellectual disability, autosomal dominant 16 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000571370 | SCV002532980 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-19 | criteria provided, single submitter | curation | |
Ce |
RCV001800593 | SCV004137793 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | SMARCA4: BP4, BP7 |